Crawford ED - Search Results

1

Maximal testosterone suppression in prostate cancer--free vs total testosterone.

Rove KO, Crawford ED, Perachino M, Morote J, Klotz L, Lange PH, Andriole GL, Matsumoto AM, Taneja SS, Eisenberger MA, Reis LO. Rove KO, et al. Among authors: crawford ed. Urology. 2014 Jun;83(6):1217-22. doi: 10.1016/j.urology.2014.02.001. Epub 2014 Apr 6. Urology. 2014. PMID: 24713136 Free PMC article. Review.

2

A framework for the identification of men at increased risk for prostate cancer.

Roobol MJ, Schröder FH, Crawford ED, Freedland SJ, Sartor AO, Fleshner N, Andriole GL. Roobol MJ, et al. Among authors: crawford ed. J Urol. 2009 Nov;182(5):2112-20. doi: 10.1016/j.juro.2009.07.018. Epub 2009 Sep 16. J Urol. 2009. PMID: 19758625 Review.

3

Reduction in the risk of prostate cancer: future directions after the Prostate Cancer Prevention Trial.

Crawford ED, Andriole GL, Marberger M, Rittmaster RS. Crawford ED, et al. Urology. 2010 Mar;75(3):502-9. doi: 10.1016/j.urology.2009.05.099. Epub 2009 Dec 29. Urology. 2010. PMID: 20035983 Review.

4

The role of 3-dimensional mapping biopsy in decision making for treatment of apparent early stage prostate cancer.

Barqawi AB, Rove KO, Gholizadeh S, O'Donnell CI, Koul H, Crawford ED. Barqawi AB, et al. Among authors: crawford ed. J Urol. 2011 Jul;186(1):80-5. doi: 10.1016/j.juro.2011.03.005. Epub 2011 May 14. J Urol. 2011. PMID: 21571335

5

Randomized controlled screening trials for prostate cancer using prostate-specific antigen: a tale of contrasts.

Rove KO, Crawford ED. Rove KO, et al. Among authors: crawford ed. World J Urol. 2012 Apr;30(2):137-42. doi: 10.1007/s00345-011-0799-4. Epub 2011 Nov 25. World J Urol. 2012. PMID: 22116599 Review.

6

Role of testosterone in managing advanced prostate cancer.

Rove KO, Debruyne FM, Djavan B, Gomella LG, Koul HK, Lucia MS, Petrylak DP, Shore ND, Stone NN, Crawford ED. Rove KO, et al. Among authors: crawford ed. Urology. 2012 Oct;80(4):754-62. doi: 10.1016/j.urology.2012.05.006. Epub 2012 Jul 13. Urology. 2012. PMID: 22795376 Review.

7

Diagnostic performance of PCA3 to detect prostate cancer in men with increased prostate specific antigen: a prospective study of 1,962 cases.

Crawford ED, Rove KO, Trabulsi EJ, Qian J, Drewnowska KP, Kaminetsky JC, Huisman TK, Bilowus ML, Freedman SJ, Glover WL Jr, Bostwick DG. Crawford ED, et al. J Urol. 2012 Nov;188(5):1726-31. doi: 10.1016/j.juro.2012.07.023. Epub 2012 Sep 19. J Urol. 2012. PMID: 22998901 Clinical Trial.

8

Androgen annihilation as a new therapeutic paradigm in advanced prostate cancer.

Rove KO, Crawford ED. Rove KO, et al. Among authors: crawford ed. Curr Opin Urol. 2013 May;23(3):208-13. doi: 10.1097/MOU.0b013e32835fa889. Curr Opin Urol. 2013. PMID: 23492838 Review.

9

The utility of prostate-specific antigen in the management of advanced prostate cancer.

Crawford ED, Bennett CL, Andriole GL, Garnick MB, Petrylak DP. Crawford ED, et al. BJU Int. 2013 Sep;112(5):548-60. doi: 10.1111/bju.12061. Epub 2013 Jul 4. BJU Int. 2013. PMID: 23826876 Review.

10

Traditional androgen ablation approaches to advanced prostate cancer: new insights.

Rove KO, Crawford ED. Rove KO, et al. Among authors: crawford ed. Can J Urol. 2014 Apr;21(2 Supp 1):14-21. Can J Urol. 2014. PMID: 24775719 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

655 results

Search Page

Filters